126 related articles for article (PubMed ID: 20149493)
1. Synthesis and pharmacological evaluation of novel fused thiophene derivatives as 5-HT2A receptor antagonists: molecular modeling study.
El-Kerdawy MM; El-Bendary ER; Abdel-Aziz AA; El-wasseef DR; El-Aziz NI
Eur J Med Chem; 2010 May; 45(5):1805-20. PubMed ID: 20149493
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor evaluation of novel diarylsulfonylurea derivatives: molecular modeling applications.
El-Sherbeny MA; Abdel-Aziz AA; Ahmed MA
Eur J Med Chem; 2010 Feb; 45(2):689-97. PubMed ID: 19939520
[TBL] [Abstract][Full Text] [Related]
3. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
Mokrosz MJ; Kowalski P; Kowalska T; Majka Z; Duszyńska B; Charakchieva-Minol S; Szaro A; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4,5,6,7-tetrahydro-N-phenylbenzo[b]thiophene-3-carboxamide.
Amr Ael-G; Sherif MH; Assy MG; Al-Omar MA; Ragab I
Eur J Med Chem; 2010 Dec; 45(12):5935-42. PubMed ID: 20950897
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.
Obniska J; Pawłowski M; Kołaczkowski M; Czopek A; Duszyńska B; Klodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):553-7. PubMed ID: 14581713
[TBL] [Abstract][Full Text] [Related]
6. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
[TBL] [Abstract][Full Text] [Related]
7. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
Paluchowska MH; Bugno R; Charakchieva-Minol S; Bojarski AJ; Wesołowska A
Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of 5,6,7,8-tetrahydro-4H-thieno[3,2-b]azepine derivatives: novel arginine vasopressin antagonists.
Cho H; Murakami K; Nakanishi H; Fujisawa A; Isoshima H; Niwa M; Hayakawa K; Hase Y; Uchida I; Watanabe H; Wakitani K; Aisaka K
J Med Chem; 2004 Jan; 47(1):101-9. PubMed ID: 14695824
[TBL] [Abstract][Full Text] [Related]
9. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2004; 56(6):743-54. PubMed ID: 15662087
[TBL] [Abstract][Full Text] [Related]
10. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
[TBL] [Abstract][Full Text] [Related]
11. Novel cyano- and N-isopropylamidino-substituted derivatives of benzo[b]thiophene-2-carboxanilides and benzo[b]thieno[2,3-c]quinolones: synthesis, photochemical synthesis, crystal structure determination, and antitumor evaluation. 2.
Jarak I; Kralj M; Suman L; Pavlović G; Dogan J; Piantanida I; Zinić M; Pavelić K; Karminski-Zamola G
J Med Chem; 2005 Apr; 48(7):2346-60. PubMed ID: 15801828
[TBL] [Abstract][Full Text] [Related]
12. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
[TBL] [Abstract][Full Text] [Related]
13. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
15. Selective kainate receptor (GluK1) ligands structurally based upon 1H-cyclopentapyrimidin-2,4(1H,3H)-dione: synthesis, molecular modeling, and pharmacological and biostructural characterization.
Venskutonyte R; Butini S; Coccone SS; Gemma S; Brindisi M; Kumar V; Guarino E; Maramai S; Valenti S; Amir A; Valadés EA; Frydenvang K; Kastrup JS; Novellino E; Campiani G; Pickering DS
J Med Chem; 2011 Jul; 54(13):4793-805. PubMed ID: 21619066
[TBL] [Abstract][Full Text] [Related]
16. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K; Liljefors T; Hyttel J; Perregaard J
J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
[TBL] [Abstract][Full Text] [Related]
17. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
[TBL] [Abstract][Full Text] [Related]
18. A new class of selective, non-basic 5-HT2A receptor antagonists.
Ladduwahetty T; Boase AL; Mitchinson A; Quin C; Patel S; Chapman K; MacLeod AM
Bioorg Med Chem Lett; 2006 Jun; 16(12):3201-4. PubMed ID: 16632354
[TBL] [Abstract][Full Text] [Related]
19. Novel N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]-ethyl]pyrid-2(1H)-ones with diversified 5-HT1A receptor activity.
Paluchowska MH; Bugno R; Charakchieva-Minol S; Wesołowska A; Chojnacka-Wójcik E
Pol J Pharmacol; 2002; 54(6):641-6. PubMed ID: 12866719
[TBL] [Abstract][Full Text] [Related]
20. CoMFA methodology in structure-activity analysis of hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives based on affinity towards 5-HT1A, 5-HT2A and alpha1-adrenergic receptors.
Maciejewska D; Zołek T; Herold F
J Mol Graph Model; 2006 Nov; 25(3):353-62. PubMed ID: 16542863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]